Dr. Roble is Director of Comparative Medicine at Fred Hutchinson Cancer Research Center. He received his MBA from NYU, his Doctor of Veterinary Medicine from Tufts University, and BA in Biology from Swarthmore College.
This person is not in the org chart
AVM Biotech
5 followers
AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment recovery, safer iPS cell culturing and treatment, and fully human biologics, including patient-specific biologics for personalized medicine (“Boutique Biologics™”) in orphan diseases.